EC Number   |
Application  |
Reference |
|---|
   2.4.1.90 | biotechnology |
enzyme can be useful in the glycosylation of cytokines, enzymes or other glycosylated compounds modifying their functions for use in medical therapies |
658123 |
| 2.4.1.90 | medicine |
an UDP-galactose: N-acetylglucosamine beta 1-4 galactosyltransferase expressing attenuated Leishmania donovani clonal population is able to confer protection against the experimental challenge with the virulent Leishmania donovani AG83 parasite |
-, 703923 |
| 2.4.1.90 | medicine |
enzyme expression is an independent prognostic factor for poor survival of neuroblastoma patients |
735973 |
| 2.4.1.90 | medicine |
the enzyme serves as a diagnostic and therapeutic biomarker for the progression of human colorectal cancer |
755974 |
| 2.4.1.90 | synthesis |
- |
489547 |
| 2.4.1.90 | synthesis |
development of a method to tag glycoproteins carrying terminal GlcNAc using the enzyme, overview |
690111 |
| 2.4.1.90 | synthesis |
enzyme can be useful in the glycosylation of cytokines, enzymes or other glycosylated compounds modifying their functions for use in medical therapies |
658123 |
| 2.4.1.90 | synthesis |
preparation of a series of specific derivatives of the complex protopanaxadiol glycoside ginsenoside Rb1 |
489541 |
| 2.4.1.90 | synthesis |
use of transformed whole yeast cells, expressing the human N-acetylglucosamine beta-1,4-galactosyltransferase, in synthesis of N-acetyllactosamine |
489547 |
